This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Other nervous system disorders
  • /
  • Tasimelteon for non-24-hour sleep�wake disorder in...
Journal

Tasimelteon for non-24-hour sleep�wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials

Read time: 2 mins
Published:31st Oct 2015
Author: Lockley SW, Dressman MA, Licamele L, Xiao C, Fisher DM, Flynn-Evans EE et al.
Source: The Lancet
Availability: Pay for access, or by subscription
Ref.:Lancet. 2015;386(10005):1754-64.
DOI:10.1016/S0140-6736(15)60031-9
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest